Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.
- Resource Type
- journal article
- Authors
- Godfrey, Anna L.; Campbell, Peter J.; MacLean, Cathy; Buck, Georgina; Cook, Julia; Temple, Julie; Wilkins, Bridget S.; Wheatley, Keith; Nangalia, Jyoti; Grinfeld, Jacob; McMullin, Mary Frances; Forsyth, Cecily; Kiladjian, Jean-Jacques; Green, Anthony R.; Harrison, Claire N.; United Kingdom Medical Research Council Primary Thrombocythemia-1 Study; United Kingdom National Cancer Research Institute Myeloproliferative Neoplasms Subgroup; French Intergroup of Myeloproliferative Neoplasms; and the Australasian Leukaemia and Lymphoma Group.; the Australasian Leukaemia and Lymphoma Group.
- Source
- Journal of Clinical Oncology; 12/1/2018, Vol. 36 Issue 34, p3361-3369, 11p
- Subject
- Language
- ISSN
- 0732183X